David Harsini, OD
Optometrist · North Las Vegas, NVNPI 1215414289
Payments from drug & device makers
Across 34 payments — averaging $50.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$496
- LKC Technologies, Inc.$248
- Bausch & Lomb, A Division Of Bausch Health US, LLC$246
- AbbVie$144
- Johnson & Johnson Vision Care, Inc.$143
- Coopervision Inc.$130
- plus $323 from 7 others
What the payments were for
- Food & beverage$1,732100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 12 | $496 |
| LKC Technologies, Inc. | 2 | $248 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $246 |
| AbbVie(2 entities) | 2 | $144 |
| Johnson & Johnson Vision Care, Inc. | 6 | $143 |
| Coopervision Inc. | 1 | $130 |
| Aerie Pharmaceuticals, Inc. | 1 | $118 |
| Bausch & Lomb Americas Inc. | 3 | $86 |
| Oyster Point Pharma, Inc. | 1 | $32 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $26 |
| Sight Sciences, Inc. | 1 | $26 |
| Novartis | 1 | $21 |
| Biotissue Holdings Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Precision7$151
- MyDay Contact Lens$130
- Precision 1$127
- BIOTRUE$125
- ULTRA$125
- BIOTRUE ONE DAY$125
- RESTASIS$125
- LOTEMAX SM$121
- Rocklatan$118
- Rhopressa$118
How this compares
$1,732 in reported general payments places this provider in the 70th percentile of 494 optometrist providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 79 | $2,273 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 39 | $489 |
| Latanoprost | 42 | $439 |
| Ketorolac Tromethamine | 14 | $282 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $225 |
| Doxycycline Hyclate | 16 | $138 |
Paid to pharmacies, not to this prescriber.
Other optometrist in North Las Vegas
- Stella LauNorth Las Vegas$100K
- Isaac OrtizNorth Las Vegas$10K
- Jennifer ChowNorth Las Vegas$7K
- Douglas DevriesSparks$1.3M
- Adam SchwartzLas Vegas$339K
- Amel YoussefLas Vegas$245K
- Eric BrookerLas Vegas$53K
- Troy HumphreysSparks$52K
- My VuongLas Vegas$47K
- Chen YoungLas Vegas$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.